Pharmacokinetic Profile
- Tadalafil has a mean terminal half-life of 17.5 hours in healthy subjects, with a mean oral clearance of 2.5 L/hr 2
- This long half-life distinguishes tadalafil from other phosphodiesterase type 5 (PDE5) inhibitors like sildenafil and vardenafil, which have half-lives of approximately 4 hours 1
- The extended half-life enables therapeutic plasma concentrations to be sustained for up to 36 hours after a single dose 3, 4, 5
Clinical Implications of the 17.5-Hour Half-Life
Nitrate Interaction Window
- Patients taking tadalafil must avoid nitroglycerine for at least 48 hours after the last dose due to the risk of severe hypotension 1
- This is a longer contraindication period compared to sildenafil or vardenafil (24 hours), directly reflecting tadalafil's longer half-life 1
- The combination of tadalafil with nitrate medications is absolutely contraindicated in patients with chronic coronary disease 1
Dosing Flexibility
- The 17.5-hour half-life makes tadalafil suitable for both on-demand dosing and once-daily continuous therapy 4, 6
- With once-daily dosing, steady-state plasma concentrations are achieved within 5 days, with exposure approximately 1.6-fold greater than after a single dose 2
- Maximum plasma concentration (Cmax) occurs between 30 minutes and 6 hours after administration (median 2 hours) 2